|Articles|March 31, 2023
- Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Advertisement
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Notable Updates in Medication Therapy Management in 2025
4
Early Signals Before Myeloma: Real-World Data Reveal Missed Opportunities for Earlier Diagnosis
5







































































































































































































